Last updated: July 29, 2025
Introduction
Patent KR20060052877, filed in South Korea, represents a critical component within the intellectual property landscape of pharmaceutical innovations in the region. This patent's scope and claims determine its exclusivity, influence over generic competition, and its strategic importance for the innovator company. Understanding the patent's detailed coverage delineates its legal robustness and the broader patent ecosystem in which it operates.
Patent Overview
- Filing and Grant Dates: The patent was filed in 2006 and granted subsequently in South Korea, with an annual expiration date generally expected in 2026, assuming standard 20-year term calculations.
- Applicant: The patent's rights typically belong to a pharmaceutical company or research organization, often linked to bio/pharma innovation.
- Priority Claims: It is crucial to assess whether the patent claims priority from earlier filings, possibly in other jurisdictions, which can influence its scope and enforceability.
Scope of the Patent
The scope of KR20060052877 centers on a specific pharmaceutical compound, formulation, or method of use, as outlined in its claims. Its breadth affects both its defensibility and the potential for competitors to design around the patent.
Primary Focus:
- The patent broadly encompasses a novel chemical compound or a pharmacologically active derivative, which exhibits specific therapeutic properties.
- It also covers a particular formulation or delivery system that enhances bioavailability, stability, or patient compliance.
- Method of use claims are included, potentially covering therapeutic applications against indicated diseases or conditions.
Scope Assessment:
- The scope is likely structured around independent claims covering the core compound or method, with dependent claims further narrowing the scope through detailed specifications.
- A narrow scope—such as specific chemical modifications—limits the patent's exclusivity, whereas broader claims related to the class of compounds or uses provide extensive protection.
Legal Robustness:
- The scope's enforceability depends on patent novelty and inventive step at filing and examination.
- Recent patent litigation trends in South Korea suggest that broadly claimed drugs must demonstrate clear novelty over prior art, including other structural analogs, to withstand invalidity attacks.
Claims Analysis
Claims Composition:
- Independent claims likely describe:
- The chemical entity with unique structural features.
- The pharmacological properties or therapeutic indications.
- The specific process for manufacturing or isolating the compound.
- Dependent claims specify:
- Additional chemical substituents or modifications.
- Specific dosage forms or administration routes.
- Combination therapies involving the claimed compound.
Claim Limitations:
- The validity of the patent hinges on the novelty of the chemical structure and its unexpected therapeutic effect.
- Prior art references, including earlier patents, scientific publications, or existing drug substances, challenge these claims if they show substantial overlap.
Claim Scope Trends:
- Modern pharmacological patents, including KR20060052877, tend toward narrower claims to avoid prior art obstacles while maximizing enforceability.
- There is an increasing emphasis on innovative use claims and formulations to extend exclusivity.
Patent Landscape Context
South Korea's Pharmaceutical Patent Environment:
- South Korea maintains a robust patent regime aligned with the World Trade Organization's TRIPS Agreement, providing patent protections typically lasting 20 years from the filing date.
- The patent examination process emphasizes novelty, inventive step, and industrial applicability, often scrutinizing chemical and pharmaceutical patents rigorously.
Competitive Patent Activity:
- The patent landscape surrounding KR20060052877 features patents from both domestic and international entities claiming similar compounds, formulations, or uses (e.g., compounds within the same chemical class or with similar therapeutic targets).
- Key competitors may file secondary patents or patent extensions (e.g., dossiers for new formulations or methods of delivery) to extend market exclusivity.
Patent Thickets and Litigation Risks:
- The broader chemical and pharmaceutical space around this patent region often exhibits dense patent thickets, creating barriers for generic entrants.
- South Korea's litigation environment is active, with patentees readily enforcing rights through administrative and judicial channels, including patent invalidation or infringement suits.
Legal Precedents and Patent Examination Insights:
- Court cases and patent office decisions in South Korea emphasize clear inventive activity, especially for pharmaceutical compounds, which influences the patent's enforceability.
- Previous decisions indicate that claims narrowly tailored and supported by robust clinical or experimental data are more likely to withstand invalidation.
Implications for Stakeholders
- Innovators: Must maintain the strategic scope of their patent claims to deter generic challenges while avoiding overly broad claims that risk invalidation.
- Generic Manufacturers: Often seek potential workarounds through design-around strategies or challenge the patent's validity via prior art.
- Regulators and IP Offices: Ensure that the patent's scope complies with patentability criteria, balancing innovation incentives with public health interests.
Conclusion
Patent KR20060052877 stands as a significant intellectual property asset within South Korea's pharmaceutical patent landscape. Its scope, centered on a novel chemical compound or formulation with therapeutic utility, reflects typical strategies for securing pharmaceutical exclusivity. The robustness of its claims and its position within a competitive patent ecosystem depend on precise claim drafting, ongoing legal scrutiny, and the evolving landscape of prior art.
Key Takeaways
- The patent’s scope likely centers on a specific chemical entity or therapeutic method, with narrower dependent claims supporting its core protection.
- Its enforceability and commercial value depend on robust claim drafting, clear novelty, and inventive step, given South Korea's rigorous patent standards.
- The patent landscape around KR20060052877 is characterized by dense patent thickets, requiring diligent freedom-to-operate assessments.
- Strategic patent extensions and secondary claims may be employed to prolong exclusivity, influencing market dynamics.
- Continuous patent examination updates and legal rulings in South Korea will shape the patent’s longevity and enforceability.
FAQs
1. What is the primary protection scope of KR20060052877?
The patent primarily protects a specific chemical compound or its therapeutic use, including particular formulations or methods of administration, depending on its claims structure.
2. How does South Korea’s patent law influence the strength of this patent?
South Korea’s patent law emphasizes novelty, inventive step, and industrial applicability. Rigid examination procedures and a history of active patent enforcement strengthen patents that meet these criteria.
3. Can competitors design around this patent?
Potentially, if they develop structurally or functionally different compounds or formulations that do not infringe on the granted claims, particularly if the patent’s scope is narrow.
4. What challenges might this patent face?
Challenges include prior art invalidation, lack of inventive step, or overlaps with existing patents, especially if broad claims are involved.
5. How does this patent landscape affect market exclusivity?
It can extend market exclusivity for a specific drug or formulation in South Korea, although secondary patents or patent challenges can impact the duration of protection.
References
[1] South Korean Patent Office records for KR20060052877.
[2] South Korea Patent Law, 2021 edition.
[3] Global patent landscape reports on pharmaceutical patents, 2022.
